BeOne Medicines Ltd ADR (NASDAQ: ONC) on Friday, soared 2.72% from the previous trading day, before settling in for the closing price of $297.96. Within the past 52 weeks, ONC’s price has moved between $170.99 and $330.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 17.26% annually for the last half of the decade. The company achieved an average annual earnings per share of 137.74%. With a float of $108.76 million, this company’s outstanding shares have now reached $109.60 million.
BeOne Medicines Ltd ADR (ONC) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of BeOne Medicines Ltd ADR is 0.77%, while institutional ownership is 31.18%. The most recent insider transaction that took place on Aug 13 ’25, was worth 15,164,818. In this transaction President and COO of this company sold 49,858 shares at a rate of $304.16, taking the stock ownership to the 0 shares. Before that another transaction happened on Aug 14 ’25, when Company’s President and COO sold 39,936 for $305.06, making the entire transaction worth $12,182,818. This insider now owns 0 shares in total.
BeOne Medicines Ltd ADR (ONC) Latest Financial update
BeOne Medicines Ltd ADR (NASDAQ: ONC) Trading Performance Indicators
BeOne Medicines Ltd ADR (ONC) is currently performing well based on its current performance indicators. A quick ratio of 1.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.35. Likewise, its price to free cash flow for the trailing twelve months is 136.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.72, a number that is poised to hit 0.70 in the next quarter and is forecasted to reach 5.96 in one year’s time.
Technical Analysis of BeOne Medicines Ltd ADR (ONC)
Let’s dig in a bit further. During the last 5-days, its volume was 0.21 million. That was inferior than the volume of 0.43 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.62%.
During the past 100 days, BeOne Medicines Ltd ADR’s (ONC) raw stochastic average was set at 81.68%, which indicates a significant increase from 48.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 8.02 in the past 14 days, which was higher than the 7.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $284.32, while its 200-day Moving Average is $241.71. However, in the short run, BeOne Medicines Ltd ADR’s stock first resistance to watch stands at $311.95. Second resistance stands at $317.85. The third major resistance level sits at $320.80. If the price goes on to break the first support level at $303.10, it is likely to go to the next support level at $300.15. The third support level lies at $294.25 if the price breaches the second support level.
BeOne Medicines Ltd ADR (NASDAQ: ONC) Key Stats
Market capitalization of the company is 33.54 billion based on 109,600K outstanding shares. Right now, sales total 3,810 M and income totals -644,790 K. The company made 1,315 M in profit during its latest quarter, and 94,320 K in sales during its previous quarter.
